The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference60 articles.
1. Updates on esophageal and gastric cancers;Gallo;World J Gastroenterol,2006
2. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741;Sanoff;J Clin Oncol,2008
3. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers;Herbst;Semin Oncol,2002
4. The EGF receptor family as targets for cancer therapy;Mendelsohn;Oncogene,2000
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring Long Noncoding RNA AC010536.1: A New Frontier in Colon Cancer Diagnosis and Prognosis;J BIOL REG HOMEOS AG;2023
2. Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers;Bioorganic Chemistry;2021-09
3. Arctigenin-mediated cell death of SK-BR-3 cells is caused by HER2 inhibition and autophagy-linked apoptosis;Pharmacological Reports;2021-03-07
4. Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview;International Journal of Molecular Sciences;2020-07-12
5. Combination of small-molecule kinase inhibitors and irinotecan in cancer clinical trials: efficacy and safety considerations;Translational Cancer Research;2017-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3